Importantly, our analysis of clinical samples revealed a significant increase in GLT1D1 mRNA expression in MCL patients (n = 11) compared with DLBCL patient samples (n = 35, P < 0.01, Fig. 1E). This evidence concerns the gene GLT1D1 and diffuse large B-cell lymphoma.